Sirtris Pharmaceuticals CEO Presents Keynote Address at the Charite Hospital Berlin, Europe’s Leading University Hospital

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sirtris Pharmaceuticals, Inc. (NASDAQ: SIRT), a biopharmaceutical company focused on discovering and developing small molecule drugs to treat diseases of aging such as Type 2 Diabetes, announced today that Chief Executive Officer and Vice Chair Christoph Westphal, M.D., Ph.D. will give the keynote address at the annual Charité Hospital/University of Berlin scientific symposium. The talk will be on Tuesday, January 22 at 5:00 pm GMT.
MORE ON THIS TOPIC